Equities

Fuji Pharma Co Ltd

Fuji Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)8.30
  • Today's Change0.25 / 3.11%
  • Shares traded350.00
  • 1 Year change-5.68%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:07 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments4,5852,3243,546
Total Receivables, Net18,87916,52012,661
Total Inventory18,00519,37115,823
Prepaid expenses109166769
Other current assets, total8877331,928
Total current assets42,46839,11434,727
Property, plant & equipment, net20,91120,54718,762
Goodwill, net11,7159,7559,744
Intangibles, net729738660
Long term investments7,09210,5877,339
Note receivable - long term------
Other long term assets1,7531,8161,300
Total assets90,00085,33275,538
LIABILITIES
Accounts payable4,1405,6726,249
Accrued expenses560883990
Notes payable/short-term debt15,30011,3008,300
Current portion long-term debt/capital leases7,6695,7242,817
Other current liabilities, total8,1266,1925,619
Total current liabilities35,79729,77123,975
Total long term debt--12,03813,571
Total debt29,25429,06224,688
Deferred income tax------
Minority interest3.002.002.00
Other liabilities, total2,3532,3462,186
Total liabilities44,44044,15739,734
SHAREHOLDERS EQUITY
Common stock3,7993,7993,799
Additional paid-in capital4,4064,4094,409
Retained earnings (accumulated deficit)34,26629,08226,546
Treasury stock - common(505)(567)(579)
Unrealized gain (loss)8852,414160
Other equity, total2,7072,0381,469
Total equity45,56041,17535,804
Total liabilities & shareholders' equity90,00085,33275,538
Total common shares outstanding242424
Treasury shares - common primary issue--0.450.46
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.